1 Choi, Y., Bowman, J. W. & Jung, J. U. Autophagy during viral infection — a double-edged sword. Nature Reviews Microbiology 16, 341-354, doi:10.1038/s41579-018-0003-6 (2018).
2 Sardiello, M. et al. A Gene Network Regulating Lysosomal Biogenesis and Function. Science 325, 473-477, doi:10.1126/science.1174447 (2009).
3 Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429-1433, doi:10.1126/science.1204592 (2011).
4 Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. The EMBO journal 31, 1095-1108, doi:10.1038/emboj.2012.32 (2012).
5 Napolitano, G. & Ballabio, A. TFEB at a glance. J Cell Sci 129, 2475-2481, doi:10.1242/jcs.146365 (2016).
6 Visvikis, O. et al. Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes. Immunity 40, 896-909, doi:10.1016/j.immuni.2014.05.002 (2014).
7 Choy, A. et al. The Legionella effector RavZ inhibits host autophagy through irreversible Atg8 deconjugation. Science 338, 1072-1076, doi:10.1126/science.1227026 (2012).
8 Köster, S. et al. Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA. Proc Natl Acad Sci U S A 114, E8711-e8720, doi:10.1073/pnas.1707792114 (2017).
9 Xu, Y. et al. A Bacterial Effector Reveals the V-ATPase-ATG16L1 Axis that Initiates Xenophagy. Cell 178, 552-566.e520, doi:10.1016/j.cell.2019.06.007 (2019).
10 Ghosh, S. et al. β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell 183, 1520-1535.e1514, doi:https://doi.org/10.1016/j.cell.2020.10.039 (2020).
11 Mindell, J. A. Lysosomal Acidification Mechanisms. Annual Review of Physiology 74, 69-86, doi:10.1146/annurev-physiol-012110-142317 (2012).
12 Kirkpatrick, G. L. The common cold. Prim Care 23, 657-675, doi:10.1016/s0095-4543(05)70355-9 (1996).
13 Glenewinkel, F. et al. The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2. Scientific reports 6, 28241, doi:10.1038/srep28241 (2016).
14 Alvarado, E. et al. Wdr68 Mediates Dorsal and Ventral Patterning Events for Craniofacial Development. PloS one 11, e0166984, doi:10.1371/journal.pone.0166984 (2016).
15 Xiang, J. et al. DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome. Proc Natl Acad Sci U S A 114, E1224-e1233, doi:10.1073/pnas.1614893114 (2017).
16 Qiu, W., Xu, C., Xiao, X. & Xu, D. Computational Prediction of Ubiquitination Proteins Using Evolutionary Profiles and Functional Domain Annotation. Curr Genomics 20, 389-399, doi:10.2174/1389202919666191014091250 (2019).
17 Chen, B. B. et al. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nature immunology 14, 470-479, doi:10.1038/ni.2565 (2013).
18 Mori, T., Gotoh, S., Shirakawa, M. & Hakoshima, T. Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function. Genes to cells : devoted to molecular & cellular mechanisms 19, 603-619, doi:10.1111/gtc.12161 (2014).
19 Zhang, C. et al. Activation of TNF-alpha/NF-kappaB axis enhances CRL4B(DCAF)(11) E3 ligase activity and regulates cell cycle progression in human osteosarcoma cells. Molecular oncology 12, 476-494, doi:10.1002/1878-0261.12176 (2018).
20 Skaar, J. R., Pagan, J. K. & Pagano, M. Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol 14, 369-381, doi:10.1038/nrm3582 (2013).
21 Robertson, H., Hayes, J. D. & Sutherland, C. A partnership with the proteasome; the destructive nature of GSK3. Biochemical pharmacology 147, 77-92, doi:10.1016/j.bcp.2017.10.016 (2018).
22 Rudolph, J. et al. Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window. J Med Chem 59, 5520-5541, doi:10.1021/acs.jmedchem.6b00638 (2016).
23 Su, Y. et al. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation. J Biomol Struct Dyn 38, 3825-3837, doi:10.1080/07391102.2019.1664330 (2020).
24 Coon, T. A. et al. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med 7, 295ra109-295ra109, doi:10.1126/scitranslmed.aab3881 (2015).
25 Lear, T. et al. Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4. The Journal of experimental medicine 213, 1029-1046, doi:10.1084/jem.20151229 (2016).
26 Nowak, A. J. et al. Chromatin-modifying complex component Nurf55/p55 associates with histones H3 and H4 and polycomb repressive complex 2 subunit Su(z)12 through partially overlapping binding sites. The Journal of biological chemistry 286, 23388-23396, doi:10.1074/jbc.M110.207407 (2011).
27 Chen, C. S., Bach, G. & Pagano, R. E. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci U S A 95, 6373-6378, doi:10.1073/pnas.95.11.6373 (1998).
28 Koval, M. & Pagano, R. E. Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal and Niemann-Pick, type A fibroblasts. J Cell Biol 111, 429-442, doi:10.1083/jcb.111.2.429 (1990).
29 Sun, N. et al. Measuring In Vivo Mitophagy. Mol Cell 60, 685-696, doi:10.1016/j.molcel.2015.10.009 (2015).
30 Banerjee, A., Kulkarni, S. & Mukherjee, A. Herpes Simplex Virus: The Hostile Guest That Takes Over Your Home. Front Microbiol 11, 733, doi:10.3389/fmicb.2020.00733 (2020).
31 Mao, J. et al. Autophagy and Viral Infection. Adv Exp Med Biol 1209, 55-78, doi:10.1007/978-981-15-0606-2_5 (2019).
32 Hekman, R. M. et al. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Molecular cell 80, 1104-1122.e1109, doi:10.1016/j.molcel.2020.11.028 (2020).
33 Van den Broeke, C., Radu, M., Chernoff, J. & Favoreel, H. W. An emerging role for p21-activated kinases (Paks) in viral infections. Trends Cell Biol 20, 160-169, doi:10.1016/j.tcb.2009.12.005 (2010).
34 Bajaj, L. et al. Lysosome biogenesis in health and disease. J Neurochem 148, 573-589, doi:10.1111/jnc.14564 (2019).
35 Irazoqui, J. E. Key Roles of MiT Transcription Factors in Innate Immunity and Inflammation. Trends Immunol 41, 157-171, doi:10.1016/j.it.2019.12.003 (2020).
36 Song, J. X., Liu, J., Jiang, Y., Wang, Z. Y. & Li, M. Transcription factor EB: an emerging drug target for neurodegenerative disorders. Drug Discov Today 26, 164-172, doi:10.1016/j.drudis.2020.10.013 (2021).
37 Antinori, S. et al. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacological research 158, 104899, doi:10.1016/j.phrs.2020.104899 (2020).
38 Grein, J. et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. The New England journal of medicine 382, 2327-2336, doi:10.1056/NEJMoa2007016 (2020).